Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Zamora-Canovas A, Marin-Quilez A, Diaz-Ajenjo L, Sanchez-Fuentes A, Gomez-Gonzalez PL, Crescente M, Fernandez-Mosteirin N, Padilla J, Gonzalez-Porras JR, Benito R, Lozano ML, Bastida JM, Rivera Pozo J. Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding. Biomolecules. 2025 Nov 21;15(12):1639. doi: 10.3390/biom15121639. PubMed PMID: 41463295; PubMed Central PMCID: PMC12730773.
AÑO: 2025; IF: 4.8
Gutierrez A, Zeberio I, Penalver FJ, Martinez-Barranco P, Perez S, Morillo D, Martin X, Nicolas C, Ferrero A, Jimenez-Ubieto A, Bastos-Oreiro M, Davila-Valls J, Calle MV, Perez M, Rodriguez G, Alonso A, Garcia-Noblejas A, Sanchez Arguello D, Knight T, Fernandez A, Lopez J, Perez De Oteyza J, Gonzalez de Villambrosia S, Perez E, Marin A, Navarro MB, Fernandez R, Gomez P, Hueso JA, Penarrubia Ponce MJ, Bravo P, Garcia-Belmonte D, De La Nuez H, Nistal S, Abrisqueta P, Ibanez F, Palomera L, Donato E, Provencio A, Infante MS, Gonzalez-Barca E. Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO. Blood Adv. 2025 Oct 14;9(19):4924-4935. doi: 10.1182/bloodadvances.2025016661. PubMed PMID: 40668613; PubMed Central PMCID: PMC12508888.
AÑO: 2025; IF: 7.1
Garcia-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, La Casta A, Ghanem I, Pulido Cortijo G, Marino Mendez A, Pazo-Cid R, Vera R, Melian M, Alcaide J, Grana B, Paez D, Gallego I, Lobo M, Borregon M, Fernandez Montes A, Martinez de Castro E, Carmona-Bayonas A, Aranda E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. Oncologist. 2025 Aug 4;30(8):oyae300. doi: 10.1093/oncolo/oyae300. PubMed PMID: 39550209; PubMed Central PMCID: PMC12395236.
AÑO: 2025; IF: 4.2
Isla D, Zugazagoitia J, Arriola E, Garcia-Campelo R, Marti Blanco C, Diz-Tain MP, Lopez-Brea M, Moreno-Vega AL, Leon-Mateos L, Oramas J, Gutierrez-Calderon V, Majem M, Sanchez-Hernandez A, Aguado C, Alvarez-Cabellos R, Massuti B, Moreno A, Firvida-Perez JL, Valdivia J, Gonzalez-Cordero M, Zafra-Poves M, Domine M, Garcia-Navalon FJ, Villanueva N, Provencio M, Juan-Vidal O, Rivas-Corredor C, Olmedo Garcia ME, Palmero R, Lopez-Castro R, Carcereny E, Lechuga JL, Dominguez M, Callejo A, Paz-Ares L. Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial. Lung Cancer. 2025 Nov;209:108763. doi: 10.1016/j.lungcan.2025.108763. Epub 2025 Sep 24. PubMed PMID: 41033130.
AÑO: 2025; IF: 4.4
Lundgren S, Huuhtanen J, Keranen M, Feng X, Patel BA, Ryland GL, Fox LC, Bravo-Perez C, Clemente M, Kerr C, Walldin G, Dufva O, Zaimoku Y, Tuononen T, Myllymaki M, Ebeling F, Jokinen E, Heinonen M, Kasanen T, Klievink J, Lahteenmaki H, Jaatinen T, Kytola S, Siitonen S, Dulau-Florea A, Braylan R, Heinaniemi M, Nakao S, Hellstrom-Lindberg E, Maciejewski JP, Blombery P, Young NS, Lahdesmaki H, Mustjoki S. Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature. Sci Transl Med. 2025 Feb 26;17(787):eadl6758. doi: 10.1126/scitranslmed.adl6758. Epub 2025 Feb 26. PubMed PMID: 40009697.
AÑO: 2025; IF: 14.6
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL